Hydrocortisone controlled release formulation
The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
31.08.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression. |
---|---|
Bibliography: | Application Number: AU20130220139 |